Clinical trial to evaluate the effect of N-acetylcysteine (NAC) in patients with moderate traumatic brain injury (MTBI)

Vice Chancellor for research of Arak University of Medical Sciences0 sites104 target enrollmentTBD

Overview

Phase: Phase 3
Intervention: Not specified
Conditions: Not specified
Sponsor: Vice Chancellor for research of Arak University of Medical Sciences
Enrollment: 104
Status: Recruiting
Last Updated: 8 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

8 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Vice Chancellor for research of Arak University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

•Patients older than 18 years old.; patients with moderate traumatic brain injury; The GCS between 9 and 13; Filling out the informed consent form by the patient or the accompanies.
•Exclusion criteria:
•Unwillingness to participate in the study; Patients who have consumed alcohol or used narcotics at anytime while diagnosed with MTBI; Patients who showed an allergic reaction to NAC

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed

Phase 2

Comparing therapeutic efficacy of N-acetyl cysteine with the combination of N-acetyl cysteine and Cimetidine in acute acetaminophen toxicityAcute acetaminophen toxicity.Poisoning by drugs, medicaments and biological substancesT36, T37,

IRCT2013102915204N1Vice chancellor for research, Mashhad University of Medical Sciences30

Recruiting

Phase 4

A clinical trial to study the effect of N-acetyl cysteine in patients with Chronic Obstructive Pulmonary Disease.Health Condition 1: null- Chronic Obstructive Pulmonary Disease

CTRI/2011/11/002138Cipla Ltd30

Recruiting

Not Applicable

acetylcysteine for cessation of tobacco smokingTobacco Use Disorder

ACTRN12617001478303Barwon Health60

Completed

Phase 3

Investigating the efficacy and safety of N-Acetyl Cysteine (NAC) inhalation spray in controlling the symptoms of patients with COVID-19

IRCT20080901001165N55Bagheiat-allah University of Medical Sciences250

Recruiting

Not Applicable

Clinical trial of acellular dermal matrix in prevention of postoperative tendon adhesion.Diseases of the musculo-skeletal system and connective tissue

KCT0004104The Catholic University of Korea, St. Vincent's Hospital26